At the time of writing, Dexcom Inc [DXCM] stock is trading at $60.23, up 3.10%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The DXCM shares have gain 3.74% over the last week, with a monthly amount drifted -15.24%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Oppenheimer downgraded its rating to Perform on September 08, 2025. On August 21, 2025, Argus initiated with a Buy rating and assigned a price target of $100 on the stock. Truist started tracking the stock assigning a Buy rating and suggested a price target of $102 on June 16, 2025. Goldman initiated its recommendation with a Buy and recommended $104 as its price target on May 30, 2025. Mizuho started tracking with an Outperform rating for this stock on April 10, 2025, and assigned it a price target of $85. In a note dated February 03, 2025, Redburn Atlantic upgraded a Buy rating on this stock and boosted its target price from $85 to $115.
For the past year, the stock price of Dexcom Inc fluctuated between $54.11 and $93.25. Currently, Wall Street analysts expect the stock to reach $83.89 within the next 12 months. Dexcom Inc [NASDAQ: DXCM] shares were valued at $60.23 at the most recent close of the market. An investor can expect a potential return of 39.28% based on the average DXCM price forecast.
Analyzing the DXCM fundamentals
According to Dexcom Inc [NASDAQ:DXCM], the company’s sales were 4.52B for trailing twelve months, which represents an 21.64% jump. Gross Profit Margin for this corporation currently stands at 0.59% with Operating Profit Margin at 0.17%, Pretax Profit Margin comes in at 0.21%, and Net Profit Margin reading is 0.16%. To continue investigating profitability, this company’s Return on Assets is posted at 0.1, Equity is 0.3 and Total Capital is 0.19. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.92.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 58.67 points at the first support level, and at 57.12 for the second support level. However, for the 1st resistance point, the stock is sitting at 61.47, and for the 2nd resistance point, it is at 62.71.
Ratios To Look Out For
It is important to note that Dexcom Inc [NASDAQ:DXCM] has a current ratio of 1.56. In addition, the Quick Ratio stands at 1.38 and the Cash Ratio stands at 0.55. Considering the valuation of this stock, the price to sales ratio is 5.20, the price to book ratio is 8.62 and price to earnings (TTM) ratio is 33.52.
Transactions by insiders
Recent insider trading involved Collins Richard Alexander, Director, that happened on Nov 14 ’25 when 2906.0 shares were sold. Director, Collins Richard Alexander completed a deal on Nov 14 ’25 to buy 2906.0 shares. Meanwhile, Director Heller Bridgette P sold 1012.0 shares on Nov 12 ’25.
